secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0001193125-23-137248
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DexCom completes $1.25B convertible notes offering, buys back $188.7M of common stock
--------------------------------------------------------------------------------

- Issued $1.25B of 0.375% convertible senior notes due 2028, including full exercise of $150M additional note option.
- Net proceeds estimated at ~$1.23B; used $101.3M for capped call transactions and $188.7M to repurchase common stock.
- Initial conversion rate 6.1571 shares per $1,000 principal (conversion price ~$162.41); notes mature May 15, 2028.
- Entered capped call transactions with counterparties to reduce potential dilution upon conversion, with cap price ~$212.62.
- Remaining proceeds to be used for capex, working capital, and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000119312523137248/0001193125-23-137248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000119312523137248/d300995d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-137248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer